Las Vegas Sands (NYSE: LVS) and Sands China today announced that Macao nongovernmental organization Sustaincia has joined the Sands Cares Accelerator, a three-year membership program aimed at advancing nonprofits to deliver greater community impact.
Recrylic – the first line of recycled acrylic to be widely available in North America – announced that it has achieved SCS Global Services’ Recycled Content Certification (RCC) and Global Recycled Standard (GRS) certification.
During a panel discussion at this year’s Consumer Electronics Show (CES), Kirti Gupta, VP of economic strategy at Qualcomm, claimed that the green outlook for 5G greatly surpasses that of previous generations of cellular technology.
Enviva Inc. (NYSE: EVA), the world’s leading producer of sustainable wood bioenergy, today announced the public release of its Corporate Sustainability Report for the year ending December 31, 2020.
The world’s soils are disappearing, which is why farmers are finding ways to work with beneficial bacteria to help crops and entire ecosystems thrive together.
Global energy consumption for mobile networks is a hot topic. Carbon footprint and costs generated by energy use is one of our industry’s greatest challenges.
NortonLifeLock and NASSCOM Foundation in India partner on the Cyber Security Skills Development Initiative for Women. The program is designed to create greater opportunities for female engineering grads by equipping them with in-demand job skills.
Learn how Johnson & Johnson sites are improving how and when we get the healthcare products and services we need and serving as a beacon to other manufacturers worldwide.
Illumina Inc. (NASDAQ: ILMN) today announced a partnership with Boehringer Ingelheim to develop companion diagnostics (CDx) for several programs in Boehringer Ingelheim's oncology pipeline. The partnership aims to accelerate the development of therapy selection and precision medicines for patients with advanced cancer.
Illumina, Inc. (NASDAQ: ILMN) today announced a multi-year partnership with Agendia N.V., a world leader in precision oncology for breast cancer, to co-develop in vitro diagnostic (IVD) tests for oncology testing. The partnership is intended to advance the use of next-generation sequencing (NGS) for decentralized oncology testing and aligns with Illumina's approach to IVD partnerships in oncology. Agendia joins Illumina's growing portfolio of more than 30 IVD partners developing over 40 sequencing-based solutions for cancer prognosis, therapy selection and other applications.
Antea Group's health and safety consultants understand what it takes to help make a positive impact on safety culture. Read blogs, insights, and more...
